Anticancer and Immunomodulatory Effects of Colchicum Speciosum Bulb Extract on MCF-7 Breast Cancer Cell
DOI:
https://doi.org/10.58600/eurjther2911Keywords:
antimicrobial activity, antiproliferative effect, apoptosis, Colchicum speciosumAbstract
Objective: Cancer is a pathophysiological condition that develops as a result of DNA damage caused by environmental mutagens and is becoming increasingly prevalent. Genetic factors, the immune system, and cytokines are reported important task the pathophysiological mechanisms of breast cancer, mostly cancer among women today. Natural plants such as Colchicum speciosum (C. speciosum) are gaining prominence in alternative therapy research due to their colchicine content and anticancer properties. Our study was conducted to evaluate the immunomodulatory and anticancer effects of C. speciosum bulb extract on MCF-7 cell.
Methods: C. speciosum was harvested and extracted; then the dose ratio was determined using the MTT method, and cytotoxicity, apoptotic level, and antibacterial activity were evaluated in MCF-7 cell. Cytokine levels were measured using commercially available kits via the ELISA method, and apoptotic assessment was examined using a commercial kit containing Annexin V-FITC/PI via fluorescence microscopy. The data was analysed statistically using GraphPad Prism (v10.2.0; GraphPad Software, ABD).
Results: In the MTT evaluation, a significant decrease in cell proliferation was observed in the 240 and 500 µg/mL applications compared to the control group, with increasing dose rate and incubation time. The cytokine profile of C. speciosum bulb was characterized by decrease of pro-inflammatory cytokines (TNF-α, IL-1β) and increase in anti-inflammatory cytokines (IL-10), while a decrease in TGF-β1 and BDNF levels was detected depending on the applied dose. Annexin V-FITC/PI analyses demonstrated that C. speciosum bulb extract elicited dose- and time-dependent apoptotic responses in MCF-7 cell. In addition, antibacterial effects of C. speciosum bulb extract were observed.
Conclusions The C. speciosum bulb was observed to have regulatory effects on cell proliferation via cytokines and apoptotic mechanisms in a dose- and time-dependent manner. Additionally, its antibacterial effect was observed independently of our findings.
References
[1] Vineis P, Wild CP (2014) Global cancer patterns: causes and prevention. Lancet. 383(9916):549–557. https://doi.org/10.1016/S0140-6736(13)62224-2
[2] Basu AK (2018) DNA damage, mutagenesis and cancer. Int J Mol Sci. 19(4):970:1-13. https://doi.org/10.3390/ijms19040970
[3] Parkinson EK, Haferkamp S, Mycielska ME (2022) Cancer cell metabolism. Int J Mol Sci. 23(13):7210:1-3. https://doi.org/10.3390/ijms23137210
[4] Roy A, DePamphilis ML (2024) Selective termination of autophagy-dependent cancers. Cells. 13(13):1096:1-25. https://doi.org/10.3390/cells13131096
[5] World Health Organization, International Agency for Research on Cancer (2018) Global Cancer Observatory: Cancer Today. Available from https://gco.iarc.fr/today
[6] Katsura C, Ogunmwonyi I, Kankam HK, Saha S (2022) Breast cancer: presentation, investigation and management. Br J Hosp Med (Lond). 83(2):1–7. https://doi.org/10.12968/hmed.2021.0459
[7] Sun X, Li D, Lv Y, Zhang M, Qiao D, Zhang Z, Ren H, Zhang Y, Yang Z, Gao J (2024) Nanomaterials for the diagnosis and treatment of triple-negative breast cancer. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 16(6):e2019:1-30.https://doi.org/10.1002/wnan.2019
[8] Obeagu EI, Obeagu GU (2024) Breast cancer: A review of risk factorsand diagnosis. Medicine(Baltimore). 103(3)e36905:1-8. https://doi.org/10.1097/MD.0000000000036905
[9] Xu H, Xu B (2023) Breast cancer: Epidemiology, risk factors and screening. Chin J Cancer Res. 35(6):565–583. https://doi.org/10.21147/j.issn.1000-9604.2023.06.02
[10] Zhou H, Cai Z, Yang Q, Yang X, Chen J, Huang T (2023) Inflammatory cytokines and two subtypes of breast cancer: A two-sample Mendelian randomization study. PLoS One. 18(11):e0293230:1-14. https://doi.org/10.1371/journal.pone.0293230
[11] Urbina-Jara LK, Rojas-Martinez A, Martinez-Ledesma E, Aguilar D, Villarreal-Garza C, Ortiz-Lopez R (2019) Landscape of germline mutations in DNA repair genes for breast cancer in Latin America: Opportunities for PARP-like inhibitors and immunotherapy. Genes (Basel). 10(10):786.1-24. https://doi.org/10.3390/genes10100786
[12] Tirada N, Aujero M, Khorjekar G, Richards S, Chopra J, Dromi S, Ioffe O (2018) Breast cancer tissue markers, genomic profiling, and other prognostic factors: A primer for radiologists. Radiographics. 38(7):1902–1920. https://doi.org/10.1148/rg.2018180047
[13] Lin HC, Lin JY (2020) M1 polarization but anti-LPS-induced inflammation and anti-MCF-7 breast cancer cell growth effects of five selected polysaccharides. Evid Based Complement Alternat Med. 9450246:1-17. https://doi.org/10.1155/2020/9450246
[14] Ngo HT, Dang VT, Nguyen NH, Bui AN, Pham PV (2023) Comparison of cytotoxic potency between freshly cultured and freshly thawed cytokine-induced killer cells from human umbilical cord blood. Cell Tissue Bank. 24(1):139–152. https://doi.org/10.1007/s10561-022-10022-8
[15] Pinzon-Charry A, Maxwell T, López JA (2005) Dendritic cell dysfunction in cancer: A mechanism for immunosuppression. Immunol Cell Biol. 83(5):451–461. https://doi.org/10.1111/j.1440-1711.2005.01371.x
[16] Bel’skaya LV, Loginova AI, Sarf EA (2022) Pro-inflammatory and anti-inflammatory salivary cytokines in breast cancer: Relationship with clinicopathological characteristics of the tumor. Curr Issues Mol Biol. 44(10):4676–4691. https://doi.org/10.3390/cimb44100319
[17] Habanjar O, Bingula R, Decombat C, Diab-Assaf M, Caldefie-Chezet F, Delort L (2023) Crosstalk of inflammatory cytokines within the breast tumor microenvironment. Int J Mol Sci. 24(4):4002:1-16. https://doi.org/10.3390/ijms24044002
[18] Tajbakhsh A, Mokhtari-Zaer A, Rezaee M, Afzaljavan F, Rivandi M, Hassanian SM, Ferns GA, Pasdar A, Avan A (2017) Therapeutic potentials of BDNF/TrkB in breast cancer: Current status and perspectives. J Cell Biochem. 118(9):2502–2515. https://doi.org/10.1002/jcb.25943
[19] Mahomoodally FM, Zengin G, Sinan KI, Yıldıztugay E, Lobine D, Ouelbani R, Bensari S, Ak G, Yılmaz MA, Gallo M, Montesano DA (2021) A comprehensive evaluation of the chemical profiles and biological properties of six geophytes from Turkey: Sources of bioactive compounds for novel nutraceuticals. Food Res Int. 140.110068:1-11. https://doi.org/10.1016/j.foodres.2020.110068
[20] Bayrak S, Sökmen M, Aytaç E, Sökmen A (2019) Conventional and supercritical fluid extraction (SFE) of colchicine from Colchicum speciosum. Ind Crops Prod. 128:80–84. https://doi.org/10.1016/j.indcrop.2018.10.060
[21] Karakaya S, Göger G, Bona GE, Yuca H, Aydın B, Tekman E, Şahin AA, Pınar NM, Güvenalp Z (2022) Screening of antimicrobial, antioxidant, antidiabetic activities, anatomical and morphological properties of C. speciosum Steven (Colchicaceae). Protoplasma. 259(6):1493–1506. https://doi.org/10.1007/s00709-022-01752-3
[22] Sevim D, Şener B (2020) Studies on anticholinesterase and antioxidant effects of samples from Colchicum L. genus of Turkish origin. FABAD J Pharm Sci. 35:195–201. https://doi.org/10.46239/ejbcs.602877
[23] Gumustas M, Polat DC, Kiliç CS, Akalin K, Ozkan SA, Coşkun M (2016) Comparison of seeds of C. speciosum and Gloriosa superba in respect to colchicine and colchicoside contents by RP-LC. Nat Prod Commun. 11(3):397–400. https://doi.org/10.1177/1934578X1601100319
[24] Senizza B, Rocchetti G, Okur MA, Zengin G, Yıldıztugay E, Ak G, Montesano D, Lucini L (2020) Phytochemical profile and biological properties of Colchicum triphyllum (meadow saffron). Foods. 9(4):457:1-13. https://doi.org/10.3390/foods9040457
[25] Davoodi A, Azadbakht M, Hosseinimehr SJ, Emami S, Azadbakht M (2021) Phytochemical profiles, physicochemical analysis, and biological activity of three Colchicum species. Jundishapur J Nat Pharm Prod. 16(2):e98868:1-8. https://doi.org/10.5812/jjnpp.98868
[26] Kari S, Subramanian K, Altomonte IA, Murugesan A, Yli-Harja O, Kandhavelu M (2022) Programmed cell death detection methods: A systematic review and a categorical comparison. Apoptosis. 27(7–8):482–508. https://doi.org/10.1007/s10495-022-01735-y
[27] Moela P, Motadi LR (2016) RBBP6: A potential biomarker of apoptosis induction in human cervical cancer cell lines. Onco Targets Ther. 9:4721–4735. https://doi.org/10.2147/OTT.S100964
[28] Baltacı C, Öz M, Fidan MS, Üçüncü O, Karataş ŞM (2022) Chemical composition, antioxidant and antimicrobial activity of C. speciosum Steven growing in Türkiye. Pak J Agric Sci. 59(5):729–736. https://doi.org/10.21162/pakjas/22.1096
[29] Zare-Bidaki M, Nabavi Sales FS, Yousefinia A, Torabi M, Aramjoo H, Ghoreishi SM, Mortazavi-Derazkola S (2025) Exploring anticancer, antifungal, antibacterial, and antioxidant properties of Colchicum luteum root-mediated silver nanoparticles with green synthesis. Plasmonics. 20(7):4589–4603. https://doi.org/10.1007/s11468-024-02591-z
[30] Falahianshafiei S, Akhtari J, Davoodi A, Pasha H (2023) Evaluation of anticancer effect of Colchicum autumnale L. corm on breast cancer cell. BMC Complement Med Ther. 23(1).357:1-11. https://doi.org/10.1186/s12906-023-04189-0
[31] Larsson S, Rønsted N (2014) Reviewing colchicaceae alkaloids: Perspectives of evolution on medicinal chemistry. Curr Top Med Chem. 14(2):274–289. https://doi.org/10.2174/1568026613666131216110417
[32] Artun FT, Karagoz A, Ozcan G, Melikoglu G, Anil S, Kultur S, Sutlupinar N (2016) In vitro anticancer and cytotoxic activities of some plant extracts on HeLa and Vero cell lines. Proceedings. 21(3):720–725. https://doi.org/10.3390/proceedings1101019
[33] Adham Foumani E, Irani S, Shokoohinia Y, Mostafaie A (2022) Colchicine of Colchicum autumnale, a traditional anti-inflammatory medicine, induces apoptosis by activation of apoptotic genes and proteins expression in human breast (MCF-7) and mouse breast (4T1) cell lines. Cell J. 24(11):647–656. https://doi.org/10.22074/cellj.2022.8290
[34] Park SH, Kim H, Kwak S, Jeong JH, Lee J, Hwang JT, Choi HK, Choi KC (2020) HDAC3-ERα selectively regulates TNF-α-induced apoptotic cell death in MCF-7 human breast cancer cells via the p53 signaling pathway. Cells. 9(5):1280:1-14. https://doi.org/10.3390/cells9051280
[35] Mercogliano MF, Bruni S, Elizalde PV, Schillaci R (2020) Tumor necrosis factor α blockade: An opportunity to tackle breast cancer. Front Oncol. 10.584:1-12. https://doi.org/10.3389/fonc.2020.00584
[36] Bonaventura A, Vecchié A, Dagna L, Tangianu F, Abbate A, Dentali F (2022) Colchicine for COVID-19: Targeting NLRP3 inflammasome to blunt hyperinflammation. Inflamm Res. 71(3):293–307. https://doi.org/10.1007/s00011-022-01540-y
[37] Suryono S, Rohman MS, Widjajanto E, Prayitnaningsih S, Wihastuti TA, Oktaviono YH (2023) Effect of colchicine in reducing MMP-9, NOX2, and TGF-β1 after myocardial infarction. BMC Cardiovasc Disord. 23(1):449:1-12 https://doi.org/10.1186/s12872-023-03464-9
[38] Yang X, Martin TA, Jiang WG (2012) Biological influence of brain-derived neurotrophic factor on breast cancer cells. Int J Oncol. 41(4):1541–1546. https://doi.org/10.3892/ijo.2012.1581
[39] Vanhecke E, Adriaenssens E, Verbeke S, Meignan S, Germain E, Berteaux N, Nurcombe V, Le Bourhis X, Hondermarck H (2011) Brain-derived neurotrophic factor and neurotrophin-4/5 are expressed in breast cancer and can be targeted to inhibit tumor cell survival. Clin Cancer Res. 17(7):1741–1752. https://doi.org/10.1158/1078-0432.CCR-10-1890
Downloads
Published
How to Cite
License
Copyright (c) 2026 Gökhan Ağtürk, Kadriye Yağmur Oruç, Aykut Oruç, Hasan Ege, Hakkı Oktay Seymen
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
